Not recruiting yet
Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA
NCT07430085 · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Updated 6 July 2026
- What is being tested
- bupivacaine-meloxicam (extended release); Bupivacaine; Ketorolac; Lidocaine (drug)
- For
- Periarticular Block; Osteoarthritis (OA); Osteoarthritis (OA) of the Knee; Pain After Surgery; Knee Arthroplasty, Total
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 89 years. About 150 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 31 July 2026, ends 28 Feb 2028. Registered 24 Feb 2026.
- Results
- None posted yet.
In the researchers' words
Prospective Cohort of patients who are scheduled for a Robot Assisted Total Knee Arthroplasty (RATKA). A prospective survey of patient reported outcome measures (Numeric Rating Scale) will be obtained postoperatively of 72 hours, as well as at the postoperative opioid consumption after 72 hours.